Medical Xpress on MSN10d
Nasal COVID-19 vaccine to enter US clinical trialsA nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
GlobalData on MSN2d
J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsThe company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.
Medical Xpress on MSN10d
Cancer vaccine shows promise for patients with stage III and IV kidney cancerDana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study: Paris Friday, February 14, 2025, 12:00 Hrs [IST] A scheduled review of the E.mbrace p ...
The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback